Latest Leverage News

Zelira Therapeutics has enhanced its financial flexibility through a $1.15 million R&D tax refund and a $1 million At-the-Market equity facility, while progressing FDA trial preparations for its HOPE® 1 autism treatment.

Aeris Environmental Ltd posted solid March quarter results, driven by its AerisTech joint venture’s initial hardware and software sales and expanding consumables segment. The company is leveraging new sustainability regulations to position its smart building ecosystem for growth.

Electro Optic Systems (EOS) reported a robust quarter ending March 2025, highlighted by significant new defence contracts and a strong cash position following the divestment of its EM Solutions subsidiary.

ReNerve Limited reported a 39% sales increase in Q3 FY25 alongside compelling clinical validation of its NervAlign® Nerve Cuff and strategic international partnerships, positioning the company for broader market penetration.

InteliCare Holdings has secured a binding agreement to trial its AI-driven platform at mecwacare’s Trescowthick Centre, marking a significant step in its commercialisation strategy within Victoria’s aged care sector.

Uscom Limited reported a 14% rise in Q3 customer receipts to $0.73 million, even as cash reserves dropped 38% to $1.34 million, reflecting increased operating costs and global market pressures.

Platina Resources has completed diamond drilling at its Xanadu Deeps gold target and is gearing up for further aircore drilling at Challa and Beete projects, maintaining a strong cash position of A$11.77 million.

Volt Resources Limited reports strong quarterly progress in graphite production and downstream development, securing new orders and partnerships while advancing US refinery plans and implementing cost-saving measures.

Codrus Minerals advances its diversified exploration portfolio with permitting progress at Bull Run and promising uranium geochemical results at Jasper Wedge, while managing costs amid challenging gold markets.

Terra Uranium Limited has expanded its exploration portfolio by acquiring LCT Metals, adding tin and precious metals projects in New South Wales, while advancing uranium exploration in Canada’s Athabasca Basin through strategic partnerships and drill-ready targets.

Echo IQ Limited marked a pivotal quarter with FDA clearance for EchoSolv AS, strategic US partnerships, and a clear path toward reimbursement and broader commercialisation.

Nova Eye Medical reported a 27% rise in Q3FY25 sales excluding China, driven by record US performance and a sharp reduction in glaucoma segment losses. The company confirmed FY25 revenue guidance and unveiled plans to expand its iTrack™ technology into ocular drug delivery.